Back-to-school season is around the corner, are your children prepared? Back to school means new clothes, new school supplies ...

A 58-year-old female from metropolitan Adelaide is in a critical condition in hospital, after being diagnosed with invasive meningococcal disease. The ...

GSK is currently the market leader in the meningococcal vaccine market, racking up sales of £1.26 billion (almost $1.6 billion) last year across the Bexsero and Menveo brands, but is having to ...

Physicians who champion immunization sustain herd immunity, reducing the incidence of severe diseases, hospitalizations, and ...

Vaccinating children well in advance allows time for the vaccines to provide the necessary protection before they are exposed ...

GSK has garnered FDA approval for its pentavalent meningococcal vaccine Penmenvy, tipped as one of its major launches for 2025 and a rival to Pfizer's first-to-market Penbraya.

A large surveillance study suggests that an extra pneumococcal vaccine dose for new care home residents can significantly ...

The Central Shenandoah Health District will offer school required immunizations for rising 7th and 12th graders in Staunton ...

GSK specialty medicines grew YoY in Q1 2025, and it is now the main profit engine, offsetting the weakness in their vaccine ...

American children’s health has declined profoundly over the past few decades, a new study shows, and the issues are so ...